FirstWord

The complete response letter cited "deficiencies" at a site that manufactures tyrosine kinase inhibitor rivoceranib.

After risvutatug rezetecan met its overall survival endpoint in a Chinese trial, GSK is advancing it outside China across multiple tumour types.

The latest approval marks the first platinum-free regimen cleared for muscle-invasive bladder cancer patients, regardless of cisplatin eligibility.

Sarclisa Escena, administered via the CirCLIQ on-body injector, is approved for multiple myeloma across all indications of the drug's intravenous formulation.

She succeeds Kendra Bence, who left the company last month to pursue a new professional opportunity.

FirstWord takes stock of the programmes and pharma deals designed to overcome the blood-brain barrier in Alzheimer's disease and beyond.

Presented interim FRONTIER4 data evaluate the long-term safety and efficacy of investigational denecimig across once-weekly, once-every-two-weeks, and once-monthly dosing in hemophilia A participants ...

HMB-002 clinical data demonstrate proof of mechanism, with dose-dependent, greater than or equal to 2.4-fold peak increases in Von Willebrand Factor (VWF) and Factor VIII (FVIII), normalization of pea...

Jordi Monés, MD, PhD, to Introduce First Direct-to-Phase 2 Randomized, Controlled Trial of Optogenetic Therapy in Macular DegenerationBenjamin Bakall, MD, PhD, to Present Durable 3-Year REMAIN Follow...

BEIJING, July 10, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), today announced that the Journal of Autoimmunity has published results from a clinical study evaluating orelabrut...